Laparoscopy and COVID-19 Contamination

Assistance Publique - Hôpitaux de Paris20 enrolled

Overview

The aim of the study is to search the presence of the SARS-COV-2 virus (COVID19) in the pneumoperitoneum of patients with a positive (or suspected) COVID19 status during a routine laparoscopy.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Covid19

Interventions

Additional and minimal collection of products of the human body carried out during a sample for standard of careOTHER

* Swab of the peritoneal fluid for traces of COVID19. The collection of peritoneal fluid is a standard care practice. * Swab from the laparoscopy filter

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient of legal age * Indication for laparoscopy * Positive (past or current) or suspected Covid19 status (cough, fever, suggestive radiological images, etc.) * Lack of opposition to participating in the study Exclusion Criteria: * Patient under legal protection * Covid19 status negative, (former or current) and not suspected * Patient unable to object * Patient with no social security care

Locations (4)

AP-HP, Bicêtre Hospital, Anesthesia Department

Le Kremlin-Bicêtre, France

RECRUITING

AP-HP, Bicêtre Hospital, Department of Digestive and Oncological Surgery

Le Kremlin-Bicêtre, France

RECRUITING

AP-HP, Bicêtre Hospital, Gynecology department

Le Kremlin-Bicêtre, France

Outcomes

Primary Outcomes

The main objective of the study is to demonstrate the presence of SARS-COV-2 in the exsufflated gas at the end of laparoscopy.

The SARS-COV-2 will be looked for in the gas before its elimination at the end of the intervention. To this end, the PCR search will be carried out on the filter used

Time frame: Day 1 , at the end of the surgery

Secondary Outcomes

The secondary objective of the study is to demonstrate the presence of SARS-COV-2 in the peritoneal fluid during laparoscopy

SARS-COV-2 will be tested for by PCR in the peritoneal fluid collected during laparoscopy

Time frame: Day 1 , at the end of the surgery

Central Contacts

Laura RUSCIO

CONTACT

+3301 45 21 34 41 laura.ruscio@aphp.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.